Colonic Epithelial miR-31 Associates with the Development of Crohn’s Phenotypes

Crohn’s disease (CD) is highly heterogeneous, due in large part to variability in cellular processes that underlie the natural history of CD, thereby confounding effective therapy. There is a critical need to advance understanding of the cellular mechanisms that drive CD heterogeneity. In this study, small RNA-sequencing and microRNA profiling in the colon revealed two distinct molecular subtypes, each with different clinical associations, in both adult and treatment-naïve pediatric CD patients. Notably, we found that microRNA-31 (miR-31) expression by itself can stratify patients into these two subtypes. Through detailed analysis of several colonic mucosa cell types from adult patients, we found that differential levels of miR-31 are particularly pronounced in epithelial cells. We generated patient crypt-derived epithelial colonoids and showed that miR-31 expression differences preserved in this ex-vivo system. In adult patients, low colonic miR-31 expression levels at the time of surgery are associated with post-operative recurrence of ileal disease. In pediatric patients, lower miR-31 expression at the time of diagnosis is associated with the future development of fibrostenotic ileal CD requiring surgery. These findings represent an important step forward in designing more effective clinical trials and developing personalized therapies for CD.

[1]  S. Mirarab,et al.  Sequence Analysis , 2020, Encyclopedia of Bioinformatics and Computational Biology.

[2]  C. Lengner,et al.  Stress responsive miR-31 is a major modulator of mouse intestinal stem cells during regeneration and tumorigenesis , 2017, eLife.

[3]  D. Watson,et al.  MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett’s esophagus , 2017, World journal of gastroenterology.

[4]  A. Griffiths,et al.  Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients. , 2017, Gastroenterology.

[5]  Judy H. Cho,et al.  Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study , 2017, The Lancet.

[6]  G. Veres,et al.  Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease. , 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[7]  Geet Duggal,et al.  Salmon: fast and bias-aware quantification of transcript expression using dual-phase inference , 2017, Nature Methods.

[8]  Praveen Sethupathy,et al.  Functional Transcriptomics in Diverse Intestinal Epithelial Cell Types Reveals Robust MicroRNA Sensitivity in Intestinal Stem Cells to Microbial Status* , 2017, The Journal of Biological Chemistry.

[9]  M. Mikuła,et al.  Genetic architecture differences between pediatric and adult-onset inflammatory bowel diseases in the Polish population , 2016, Scientific Reports.

[10]  Christopher A. Miller,et al.  Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases , 2016, PLoS medicine.

[11]  Daehyun Baek,et al.  General rules for functional microRNA targeting , 2016, Nature Genetics.

[12]  Adam Robinson,et al.  Molecular classification of Crohn's disease reveals two clinically relevant subtypes , 2016, Gut.

[13]  Tariq Ahmad,et al.  Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study , 2016, The Lancet.

[14]  Olga Kovbasnjuk,et al.  Human Enteroids/Colonoids and Intestinal Organoids Functionally Recapitulate Normal Intestinal Physiology and Pathophysiology* , 2015, The Journal of Biological Chemistry.

[15]  Terrence S. Furey,et al.  MicroRNAs Classify Different Disease Behavior Phenotypes of Crohn's Disease and May Have Prognostic Utility , 2015, Inflammatory bowel diseases.

[16]  X. Yang,et al.  MicroRNA profiling of the intestine during hypothermic circulatory arrest in swine. , 2015, World journal of gastroenterology.

[17]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[18]  K. Tomczak,et al.  The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge , 2015, Contemporary oncology.

[19]  J. Pekow,et al.  The emerging role of miRNAs in inflammatory bowel disease: a review , 2015, Therapeutic advances in gastroenterology.

[20]  P. Lakatos,et al.  Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature. , 2014, Journal of Crohn's & colitis.

[21]  M. Schmidt,et al.  MicroRNAs regulate tight junction proteins and modulate epithelial/endothelial barrier functions , 2014, Tissue barriers.

[22]  Timothy L. Tickle,et al.  Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. , 2014, The Journal of clinical investigation.

[23]  Steven J. M. Jones,et al.  Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.

[24]  J. Xu,et al.  A systematic analysis of predicted MiR-31-targets identifies a diagnostic and prognostic signature for lung cancer. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[25]  Noah C. Welker,et al.  Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity , 2014, Modern Pathology.

[26]  P. Sethupathy,et al.  Beta Cell 5′-Shifted isomiRs Are Candidate Regulatory Hubs in Type 2 Diabetes , 2013, PloS one.

[27]  Joshua M. Stuart,et al.  Integrated genomic characterization of endometrial carcinoma , 2013, Nature.

[28]  N. Shaheen,et al.  Defective Barrier Function in Neosquamous Epithelium , 2013, The American Journal of Gastroenterology.

[29]  F. Smets,et al.  Diagnosing and treating pediatric Crohn's disease patients: is there a difference between adult and pediatric gastroenterologist's practices ? Results of the BELCRO cohort. , 2013, Acta gastro-enterologica Belgica.

[30]  J. Pekow,et al.  MicroRNAs in inflammatory bowel disease , 2012, Inflammatory bowel diseases.

[31]  P. Munkholm,et al.  Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease – a population‐based study , 2011, Alimentary pharmacology & therapeutics.

[32]  Jonathan Schug,et al.  MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. , 2010, Gastroenterology.

[33]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[34]  A. Schäffer,et al.  Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. , 2009, The New England journal of medicine.

[35]  M. Grigorov,et al.  Biomarkers of human gastrointestinal tract regions , 2009, Mammalian Genome.

[36]  L. Staudt,et al.  Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways , 2008, Proceedings of the National Academy of Sciences.

[37]  T. Hibi,et al.  Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. , 2008, The Journal of clinical investigation.

[38]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[39]  P. Rutgeerts,et al.  Predictability of the postoperative course of Crohn's disease. , 1990, Gastroenterology.

[40]  Praveen Sethupathy,et al.  miRquant 2.0: an Expanded Tool for Accurate Annotation and Quantification of MicroRNAs and their isomiRs from Small RNA-Sequencing Data , 2016, Journal of integrative bioinformatics.

[41]  Judy H. Cho,et al.  Materials for : Host-microbe interactions shape genetic risk for inflammatory bowel disease , 2012 .